# A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors

> **NCT00268905** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 64 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** E7389 + carboplatin AUC 5
- **DRUG:** E7389 + carboplatin AUC 6
- **DRUG:** E7389+carboplatin AUC 6

## Key facts

- **NCT ID:** NCT00268905
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2011-11
- **Final completion:** —
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00268905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00268905, "A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00268905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*